Altshuler Shaham’s NEVRO CORP. NVRO Stock Holding History

Altshuler Shaham’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-224	Closed	-$39K	–	547
2020 Q4	$39K	Buy	+224	New	+$36.3K	﹤0.01%	308
2020 Q3	–	Sell	-157	Closed	-$19K	–	428
2020 Q2	$19K	Sell	157 -70	-31%	-$8.3K	﹤0.01%	267
2020 Q1	$23K	Sell	227 -49	-18%	-$5.89K	﹤0.01%	227
2019 Q4	$32K	Buy	276 +165	+149%	+$16.3K	﹤0.01%	215
2019 Q3	$9K	Buy	+111	New	+$8.4K	﹤0.01%	310

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Altshuler Shaham's NVRO Position: Q1 2021 in Review

Altshuler Shaham sold out of NEVRO CORP. (NVRO) in Q1 2021, closing a stake of 224 shares — an estimated $39K sold.

Altshuler Shaham first reported a position in NVRO in Q3 2019 and held it in 5 quarters. The position peaked at $39K in Q4 2020. 204 funds tracked by Wall St. Rank hold NVRO as of Q1 2021.

Altshuler Shaham reported no remaining NEVRO CORP. position as of Q1 2021 after selling out during the quarter.
Altshuler Shaham sold 224 NEVRO CORP. shares in Q1 2021, an estimated $39K.
Altshuler Shaham first reported a position in NEVRO CORP. in Q3 2019 and held it in 5 quarters.
Altshuler Shaham's NEVRO CORP. position peaked at $39K in Q4 2020.
204 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2021.

Based on Altshuler Shaham's 13F filing for Q1 2021, filed 13 May 2021.